Medscape is available in 5 Language Editions – Choose your Edition here.


Acute Angle-Closure Glaucoma

  • Author: Joseph Freedman, MD; Chief Editor: Steven C Dronen, MD, FAAEM  more...
Updated: Aug 22, 2016


Glaucoma is a nonspecific term used for several ocular diseases that ultimately result in increased intraocular pressure (IOP) and decreased visual acuity. Acute angle-closure glaucoma (AACG) is an ocular emergency and receives distinction due to its acute presentation, need for immediate treatment, and well-established anatomic pathology.[1] Rapid diagnosis, immediate intervention, and referral can have profound effects on patient outcome and morbidity.

The acute angle closure literature has been plagued by the lack of a uniform definition and specific diagnostic criteria. Only in recent years has there been a strong push to standardize the definitions of the various forms of angle closure disease. Primary angle closure, primary angle-closure glaucoma, acute angle closure, and acute angle-closure glaucoma were previously used interchangeable. Now, acute angle closure is defined as at least 2 of the following symptoms: ocular pain, nausea/vomiting, and a history of intermittent blurring of vision with halos; and at least 3 of the following signs: IOP greater than 21 mm Hg, conjunctival injection, corneal epithelial edema, mid-dilated nonreactive pupil, and shallower chamber in the presence of occlusion.

Primary angle closure is defined as an occludable drainage angle and features indicating that trabecular obstruction by the peripheral iris has occurred (ie, peripheral anterior synechiae, increased IOP, distortion of iris fibers [iris whorling], lens opacities, excessive trabecular pigmentation deposits). An eye in which contact between the peripheral iris and the posterior trabecular meshwork is considered possible based on ocular anatomy is termed primary angle closure suspect. The term glaucoma is added if glaucomatous optic neuropathy is present.



AACG represents the end stage of processes resulting in the compromised egress of aqueous humor circulation and the subsequent increase in IOP. Aqueous humor is produced by the ciliary body in the posterior chamber of the eye. It diffuses from the posterior chamber, through the pupil, and into the anterior chamber. From the anterior chamber, the fluid is drained into the vascular system via the trabecular meshwork and Schlemm canal contained within the angle.

Several anatomic abnormalities lead to anterior chamber crowding and predispose individuals to AACG. These include shallower anterior chambers, thinner ciliary bodies, a thinner iris, anteriorly situated thicker lens,[2] and a shorter axial eye length. Recent studies have suggested that increased iris thickness and cross-sectional area are associated with increased risk.[3] Of the many predisposing anatomical variations, a narrow angle has the most devastating consequences.

In the traditional model of AACG, the eye's natural response of dilation to environmental or chemical stimuli results in a pathologic iris-lens apposition. The apposition and contact between the lens and the iris is called pupillary block. Furthermore, pupillary block describes a state in which the forward-most surface of the lens is anterior to the plane of the iris insertion into the ciliary body. As a result, aqueous flow from the posterior chamber to the anterior chamber is obstructed or altogether blocked. When pupillary block occurs in conjunction with the iris, the increasing pressure in the posterior chamber causes the pliable iris, particularly the peripheral region, to bow forward in a process termed iris bombé. Iris bombé further closes the already narrow angle and compromises aqueous drainage, thus increasing IOP.

Recent research has suggested an alternative pathophysiologic pathway for AACG. Cronemberger et al propose that acute events can be traced to an autonomic imbalance in individuals with AACG, specifically increased sympathetic tone. Furthermore, the iris dilator muscles in these individuals have been found to be more developed and stronger. In instances of increased ocular sympathetic tone, including emotional distress, low light conditions, or after sympathomimetic drug use, contraction of the iris dilator muscles leads to pupil dilatation and thickening of the middle-peripheral iris. This thickening can lead to angle closure, thereby obstructing the outflow of aqueous humor.[4]

Other proposed mechanisms of AACG include plateau iris, lens swelling, and ciliary block. Plateau iris is less common than pupillary block and is due to anterior insertion of the iris. The superfluous and crowded iris tissue blocks the trabecular meshwork and again leads to increased IOP.

Lens swelling and ciliary block are extremely rare. Lens swelling occurs in cases of cataracts in which hydration forces cause enlargement of the lens and subsequent crowding of the anterior chamber. Forces posterior to the lens can push the lens and iris forward causing ciliary block or vitreous pressure. This can be seen in panretinal photocoagulation, scleral buckles, and uveitis.




United States

AACG occurs between 1 and 40 times for every 1000 Americans depending on their ethnicity.


Outcome after AACG is dependent on duration from onset to treatment, underlying ocular disease, and ethnicity. The degree of IOP elevation has been shown to have less impact on future visual acuity. Studies report that as many as two thirds of individuals with AACG had no visual field loss. However, Asians appear to be more refractory to the initial medical management, and, even after definitive treatment, they experience a progressive increase in IOP and deterioration in visual acuity.[5]


AACG occurs in 1 of 1000 whites, about 1 in 100 Asians, and as many as 2-4 of 100 Eskimos.[6, 7]


AACG predominately affects females because of their shallower anterior chamber.


Elderly patients in their sixth and seventh decades of life are at greatest risk.

Contributor Information and Disclosures

Joseph Freedman, MD Resident Physician, Department of Emergency Medicine, State University of New York Downstate, King's County Hospital Center

Joseph Freedman, MD is a member of the following medical societies: Emergency Medicine Residents' Association

Disclosure: Nothing to disclose.


Richard H Sinert, DO Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Vice-Chair in Charge of Research, Department of Emergency Medicine, Kings County Hospital Center

Richard H Sinert, DO is a member of the following medical societies: American College of Physicians, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Andrew Aherne, MD Resident Physician, Department of Emergency Medicine, Kings County Hospital Center, University Hospital of Brooklyn

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Douglas Lavenburg, MD Clinical Professor, Department of Emergency Medicine, Christiana Care Health Systems

Douglas Lavenburg, MD is a member of the following medical societies: American Society of Cataract and Refractive Surgery

Disclosure: Nothing to disclose.

Chief Editor

Steven C Dronen, MD, FAAEM Chair, Department of Emergency Medicine, LeConte Medical Center

Steven C Dronen, MD, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.


Ayim K Darkeh, MD Assistant Professor, Department of Emergency Medicine, State University of New York Downstate Medical Center

Ayim K Darkeh is a member of the following medical societies: American College of Emergency Physicians, Emergency Medicine Residents Association, National Medical Association, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Michelle Ervin, MD Chair, Department of Emergency Medicine, Howard University Hospital

Michelle Ervin, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, National Medical Association, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Mark A Silverberg, MD, MMB, FACEP Assistant Professor, Associate Residency Director, Department of Emergency Medicine, State University of New York Downstate College of Medicine; Consulting Staff, Department of Emergency Medicine, Staten Island University Hospital, Kings County Hospital, University Hospital, State University of New York Downstate Medical Center

Mark A Silverberg, MD, MMB, FACEP is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, Council of Emergency Medicine Residency Directors, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

  1. Berkoff DJ, Sanchez LD. An uncommon presentation of acute angle closure glaucoma. J Emerg Med. 2005 Jul. 29(1):43-4. [Medline].

  2. Yip LW, Aquino MC, Chew PT. Measurement of anterior lens growth after acute primary angle-closure glaucoma. Can J Ophthalmol. 2007 Apr. 42(2):321-2. [Medline].

  3. Wang BS, Narayanaswamy A, Amerasinghe N, Zheng C, He M, Chan YH, et al. Increased iris thickness and association with primary angle closure glaucoma. Br J Ophthalmol. 2010 Jun 7. [Medline].

  4. Cronemberger S, Calixto N, de Andrade AO, Mérula RV. New considerations on pupillary block mechanism. Arq Bras Oftalmol. 2010 Feb. 73(1):9-15. [Medline].

  5. Ang LP, Ang LP. Current understanding of the treatment and outcome of acute primary angle-closure glaucoma: an Asian perspective. Ann Acad Med Singapore. 2008 Mar. 37(3):210-5. [Medline].

  6. He M, Foster PJ, Ge J, Huang W, Zheng Y, Friedman DS. Prevalence and clinical characteristics of glaucoma in adult Chinese: a population-based study in Liwan District, Guangzhou. Invest Ophthalmol Vis Sci. 2006 Jul. 47(7):2782-8. [Medline].

  7. Vijaya L, George R, Arvind H, Baskaran M, Paul PG, Ramesh SV. Prevalence of angle-closure disease in a rural southern Indian population. Arch Ophthalmol. 2006 Mar. 124(3):403-9. [Medline].

  8. Rahim SA, Sahlas DJ, Shadowitz S. Blinded by pressure and pain. Lancet. 2005 Jun 25-Jul 1. 365(9478):2244. [Medline].

  9. Cholongitas E, Pipili C, Dasenaki M. Acute angle closure glaucoma presented with nausea and epigastric pain. Dig Dis Sci. 2008 May. 53(5):1430-1. [Medline].

  10. Croos R, Thirumalai S, Hassan S, Davis Jda R. Citalopram associated with acute angle-closure glaucoma: case report. BMC Ophthalmol. 2005 Oct 4. 5:23. [Medline]. [Full Text].

  11. Natesh S, Rajashekhara SK, Rao AS, Shetty B. Topiramate-induced angle closure with acute myopia, macular striae. Oman J Ophthalmol. 2010 Jan. 3(1):26-8. [Medline]. [Full Text].

  12. Subak-Sharpe I, Low S, Nolan W, Foster PJ. Pharmacological and environmental factors in primary angle-closure glaucoma. Br Med Bull. 2010. 93:125-43. [Medline].

  13. Etminan M, Maberley D, Mikelberg FS. Use of topiramate and risk of glaucoma: a case-control study. Am J Ophthalmol. 2012 May. 153(5):827-30. [Medline].

  14. Tse DM, Titchener AG, Sarkies N, Robinson S. Acute angle closure glaucoma following head and orbital trauma. Emerg Med J. 2009 Dec. 26(12):913. [Medline].

  15. Hunter TG, Chong GT, Asrani S, Allingham RR, Blumberg DM. Simultaneous bilateral angle closure glaucoma in a patient with giant cell arteritis. J Glaucoma. 2010 Feb. 19(2):149-50. [Medline].

  16. Singer MS, Salim S. Bilateral acute angle-closure glaucoma as a complication of facedown spine surgery. Spine J. 2010 Sep. 10(9):e7-9. [Medline].

  17. Day AC, Nolan W, Malik A, Viswanathan AC, Foster PJ. Pilocarpine induced acute angle closure. BMJ Case Rep. 2012 May 8. 2012:[Medline].

  18. Choong YF, Irfan S, Menage MJ. Acute angle closure glaucoma: an evaluation of a protocol for acute treatment. Eye (Lond). 1999 Oct. 13 ( Pt 5):613-6. [Medline].

  19. Masselos K, Bank A, Francis IC, Stapleton F. Corneal indentation in the early management of acute angle closure. Ophthalmology. 2009 Jan. 116(1):25-9. [Medline].

  20. Mansouri K, Ravinet E. Argon-laser iridoplasty in the management of uveitis-induced acute angle-closure glaucoma. Eur J Ophthalmol. 2009 Mar-Apr. 19(2):304-6. [Medline].

  21. Sun X, Liang YB, Wang NL, Fan SJ, Sun LP, Li SZ. Laser peripheral iridotomy with and without iridoplasty for primary angle-closure glaucoma: 1-year results of a randomized pilot study. Am J Ophthalmol. 2010 Jul. 150(1):68-73. [Medline].

  22. Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002 Feb. 86(2):238-42. [Medline]. [Full Text].

  23. Ang LP, Aung T, Chua WH, Yip LW, Chew PT. Visual field loss from primary angle-closure glaucoma: a comparative study of symptomatic and asymptomatic disease. Ophthalmology. 2004 Sep. 111(9):1636-40. [Medline].

  24. Aung T, Friedman DS, Chew PT, et al. Long-term outcomes in asians after acute primary angle closure. Ophthalmology. 2004 Aug. 111(8):1464-9. [Medline].

  25. Aung T, Oen FT, Wong HT, et al. Randomised controlled trial comparing the effect of brimonidine and timolol on visual field loss after acute primary angle closure. Br J Ophthalmol. 2004 Jan. 88(1):88-94. [Medline]. [Full Text].

  26. Blake DR, Nathan DM. Acute angle closure glaucoma following rapid correction of hyperglycemia. Diabetes Care. 2003 Nov. 26(11):3197-8. [Medline].

  27. Bonomi L, Marchini G, Marraffa M, et al. Epidemiology of angle-closure glaucoma: prevalence, clinical types, and association with peripheral anterior chamber depth in the Egna-Neumarket Glaucoma Study. Ophthalmology. 2000 May. 107(5):998-1003. [Medline].

  28. Fourman S. Diagnosing acute angle-closure glaucoma: a flowchart. Surv Ophthalmol. 1989 May-Jun. 33(6):491-4. [Medline].

  29. Fricke TR, Mantzioros N, Vingrys AJ. Management of patients with narrow angles and acute angle-closure glaucoma. Clin Exp Optom. 1998 Nov-Dec. 81(6):255-266. [Medline].

  30. Gohdo T, Tsumura T, Iijima H, Kashiwagi K, Tsukahara S. Ultrasound biomicroscopic study of ciliary body thickness in eyes with narrow angles. Am J Ophthalmol. 2000 Mar. 129(3):342-6. [Medline].

  31. Kramer P, Ritch R. The treatment of acute angle-closure glaucoma revisited. Ann Ophthalmol. 1984 Dec. 16(12):1101-3. [Medline].

  32. Lam D, Tham C, Lai J, et al. Current approaches to management of acute primary angle closure. Curr Opinion Ophthalmol. 2001. 18:146-151.

  33. Lim LS, Aung T, Husain R, Wu YJ, Gazzard G, Seah SK. Acute primary angle closure: configuration of the drainage angle in the first year after laser peripheral iridotomy. Ophthalmology. 2004 Aug. 111(8):1470-4. [Medline].

  34. Lowe RF. Aetiology of the anatomical basis for primary angle-closure glaucoma. Biometrical comparisons between normal eyes and eyes with primary angle-closure glaucoma. Br J Ophthalmol. 1970 Mar. 54(3):161-9. [Medline]. [Full Text].

  35. MacCumber M. Management of Ocular Injuries and Emergencies. 1998. 237-240:

  36. Markowitz SN, Morin JD. Angle-closure glaucoma: relation between lens thickness, anterior chamber depth and age. Can J Ophthalmol. 1984 Dec. 19(7):300-2. [Medline].

  37. Ritch R. Assessing the treatment of angle closure. Ophthalmology. 2003 Oct. 110(10):1867-8. [Medline].

  38. Salmon JF. The management of acute angle-closure glaucoma. Eye (Lond). 1999 Oct. 13 ( Pt 5):609-10. [Medline].

  39. Saw SM, Gazzard G, Friedman DS. Interventions for angle-closure glaucoma: an evidence-based update. Ophthalmology. 2003 Oct. 110(10):1869-78; quiz 1878-9, 1930. [Medline].

  40. Senthil S, Garudadri C, Rao HB, Maheshwari R. Bilateral simultaneous acute angle closure caused by sulphonamide derivatives: a case series. Indian J Ophthalmol. 2010 May-Jun. 58(3):248-52. [Medline]. [Full Text].

  41. Tarongoy P, Ho CL, Walton DS. Angle-closure glaucoma: the role of the lens in the pathogenesis, prevention, and treatment. Surv Ophthalmol. 2009 Mar-Apr. 54(2):211-25. [Medline].

  42. Yusuf IH, Shah M, Shaikh A, James CB. Transscleral cyclophotocoagulation in refractory acute and chronic angle closure glaucoma. BMJ Case Rep. 2015 Sep 30. 2015:[Medline].

  43. Achiron A, Aviv U, Mendel L, Burgansky-Eliash Z. Acute angle closure glaucoma precipitated by olanzapine. Int J Geriatr Psychiatry. 2015 Oct. 30 (10):1101-2. [Medline].

  44. Singh P, Rijal AP. Effectivity of Nd Yag PI in treatment of acute primary angle closure glaucoma. Nepal Med Coll J. 2014 Sep. 16 (1):45-9. [Medline].

All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.